Načítá se...
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
The incorporation of various novel therapies has resulted in a significant survival benefit in newly diagnosed and relapsed patients with multiple myeloma (MM) over the past decade. Despite these advances, resistance to therapy leads to eventual relapse and fatal outcomes in the vast majority of pat...
Uloženo v:
| Vydáno v: | Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4866749/ https://ncbi.nlm.nih.gov/pubmed/27226735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S94021 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|